Targeting VAV1, VAV2, and VAV3 in Atherosclerosis: A Multi-Omics, Drug Repurposing, and Experimental Validation Study

SSRN Electronic Journal 2026 Preprint Open access

Read full text

Authors: Prerna B. Bansal, Kamna Srivastava

DOI: 10.2139/ssrn.6297499

Cited by: 0

Fields of Study & Subjects

Computational Drug Discovery Methods Atherosclerosis and Cardiovascular Diseases Protein Kinase Regulation and GTPase Signaling